In the in vivo experiments we demonstrated the capacity of ReNcells CX injectedinto systemic circulation, to migrate to intracerebral glioma C6 and confirmed our invitro findings, by showing an increased expression of HGF, VEGF and zonulin in theintracranial tumor. This evidence concerns the gene VEGFA and central nervous system cancer.